Join to View Full Profile
300 W 10th AveColumbus, OH 43210
Phone+1 614-293-4448
Fax+1 614-293-3277
Dr. Giglio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Pierre Giglio is a neurologist in Columbus, OH and is affiliated with James Cancer Hospital and Solove Research Institute. He received his medical degree from University of Malta School of Medicine and has been in practice 26 years. He specializes in neurophysiology and neurooncology.
Education & Training
University of ChicagoFellowship, Clinical Neurophysiology, 2003 - 2004
University at BuffaloResidency, Neurology, 1998 - 2001- University at BuffaloInternship, Internal Medicine, 1997 - 1998
University of Malta School of MedicineClass of 1993
Certifications & Licensure
OH State Medical License 2014 - 2027
SC State Medical License 2006 - 2025
IL State Medical License 2003 - 2004
American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant with RT & TMZ for the Treatment of Newly Diagnosed GBM Start of enrollment: 2020 Dec 08
Roles: Contact
- Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers Start of enrollment: 2017 Jul 13
Roles: Contact
Publications & Presentations
PubMed
- Boswellia Serrata for Cerebral Radiation Necrosis After Radiosurgery for Brain Metastases.Rituraj Upadhyay, Ahmed Nader Mohammed Elguindy, Laura Salts, Kari Donovan, Soma Sengupta
International Journal of Radiation Oncology, Biology, Physics. 2025-02-23 - Early Repeat Residual Resection Versus Adjuvant Therapy for Incompletely Resected Glioblastoma: A Case-Control Study.Mark A Damante, Joshua Vignolles-Jeong, Guilherme Finger, Daniel Kreatsoulas, Santino Cua
Neurosurgery. 2025-02-21 - Papillary craniopharyngioma management in the era of BRAF and MEK inhibition.Mark Damante, Santino Cua, Daniel Kreatsoulas, Pierre Giglio, Luma Ghalib
Journal of Neuro-Oncology. 2025-02-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
